Pfizer Hit With Suit Claiming Lipitor Caused Diabetes

Law360, New York (October 9, 2013, 12:37 PM EDT) -- Pfizer Inc. was sued Tuesday by a Louisiana woman claiming she developed Type 2 diabetes after taking Pfizer’s blockbuster cholesterol treatment Lipitor for roughly a decade starting in the late 1990s and that the drug giant fraudulently hid Lipitor’s potential link to blood sugar levels until 2012.

In a complaint filed in Louisiana federal court, Gladys Board claimed that Pfizer had not included a warning about increased glucose levels associated with Lipitor until after the U.S. Food and Drug Administration asked it to do so in 2011, based on its review of the drug.

And even this warning does not sufficiently...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Louisiana Middle

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Subscribers Only

Date Filed

October 8, 2013

Companies

Government Agencies